LUNG vs NVCR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

LUNG

55.1
AI Score
VS
LUNG Wins

NVCR

49.8
AI Score

Investment Advisor Scores

LUNG

55score
Recommendation
HOLD

NVCR

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LUNG NVCR Winner
Forward P/E 28.3286 909.0909 LUNG
PEG Ratio 0 -0.47 Tie
Revenue Growth -4.6% 15.6% NVCR
Earnings Growth 0.0% -6.0% LUNG
Tradestie Score 55.1/100 49.8/100 LUNG
Profit Margin -55.0% -21.2% NVCR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LUNG 1M: -19.7% · 3M: +23.6% NVCR 1M: -16.2% · 3M: -13.7%

Current Technical Phase

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.0 · Price: $1.83

NVCR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.5%), weak momentum, RSI 34

RSI (14): 34.3 · Price: $14.94

Fundamentals Snapshot

Metric LUNG NVCR
Market Cap — —
Forward P/E -1.9 -18.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.8% 0.8%
Operating Margin -0.4% -0.1%
EPS -1.15 -1.30
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.